Indications and Purposes
| 1 Indications And Usage Belrapzo Is An Alkylating Drug Indicated For Treatment Of Patients With: Chronic Lymphocytic Leukemia (Cll). Efficacy Relative To First Line Therapies Other Than Chlorambucil Has Not Been Established. ( 1.1 ) Indolent B-Cell Non-Hodgkin Lymphoma (Nhl) That Has Progressed During Or Within Six Months Of Treatment With Rituximab Or A Rituximab-Containing Regimen. ( 1.2 ) 1.1 Chronic Lymphocytic Leukemia (Cll) Belrapzo Is Indicated For The Treatment Of Patients With Chronic Lymphocytic Leukemia. Efficacy Relative To First Line Therapies Other Than Chlorambucil Has Not Been Established. 1.2 Non-Hodgkin Lymphoma (Nhl) Belrapzo Is Indicated For The Treatment Of Patients With Indolent B-Cell Non-Hodgkin Lymphoma That Has Progressed During Or Within Six Months Of Treatment With Rituximab Or A Rituximab-Containing Regimen. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Bendamustine Hydrochloride |
|
ZINC4214955 |